Old Web
English
Sign In
Acemap
>
authorDetail
>
Sahar Ansari
Sahar Ansari
Seattle Genetics
Medicine
Internal medicine
Oncology
Brentuximab vedotin
Nivolumab
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models
2020
Journal for ImmunoTherapy of Cancer
Weiping Zeng
Haley Neff-Laford
Sahar Ansari
Celine Jacquemont
Michael Schmitt
Shyra J. Gardai
Show All
Source
Cite
Save
Citations (0)
Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study
2019
Blood
Alison J. Moskowitz
Ranjana H. Advani
Nancy L. Bartlett
Julie M. Vose
Radhakrishnan Ramchandren
Tatyana Feldman
Ann S. LaCasce
Beth A. Christian
Stephen M. Ansell
Craig H. Moskowitz
Lisa Brown
David Taft
Sahar Ansari
Daniel E. Zak
Mariana Sacchi
Thomas Manley
Alex F. Herrera
Show All
Source
Cite
Save
Citations (14)
1